Insight into the Anxious Learner: Research and Intervention

Presenter: Hilary Murphy, Ph.D.
Neuropsychologist, CNNH NeuroHealth

View the webinar’s corresponding slides here        Download the Webinar

The negative impact of anxiety on all areas of cognitive functioning, particularly attention and learning, has been well established in educational and psychological research. However, more recent studies suggest that the relationship between these variables is more complex than originally theorized. This workshop will provide a review of the theories of academic anxiety, discuss facets of executive functioning, and clarify the relationship between these factors and student performance in individuals with and without learning disabilities. Special emphasis will be given to how this information can be used to better understand student behavior and support general well-being.

Hilary Murphy Ph.D. is a licensed clinical psychologist and formally trained pediatric neuropsychologist with a specialization in the neuropsychological assessment of neurodevelopmental and neuro-medical disorders. Dr. Murphy has extensive experience evaluating children, adolescents, and young adults. As part of her training, she participated in interdisciplinary treatment teams, on an inpatient and outpatient context, to treat clients presenting with a variety of neurological, neurodevelopmental, and psychological needs. Her training in school psychology provides her with expertise in collaborating and consulting with educators and other professionals to develop comprehensive, individualized educational and treatment plans. She adopts a multi-faceted approach to neuropsychological assessment, which takes an individual’s culture, social-emotional functioning, cognitive profile, and academic performance, into account to develop a holistic understanding of each patient’s unique presentation. Her areas of expertise include Attention-Deficit-Hyperactivity Disorder (ADHD), dyslexia and other specific learning disabilities, Traumatic Brain Injury (TBI), concussion, epilepsy, neuro-oncology and late effects of chemotherapy, stroke, and developmental disabilities.

Comments are closed.